Application note: A novel way to expedite antibody discovery
Analyse isotype titer and cell health in one assay...
List view / Grid view
Analyse isotype titer and cell health in one assay...
Study uncovers new potential therapeutic approach for a number of diseases linked to inflammation, including atherosclerosis, aortic stenosis and hepatic steatosis...
For most people, traditional High-Throughput Screening (HTS) represents large automation rigs and large libraries of small molecules screened against drug targets, however, the development of biological therapeutics has been gaining considerable pace for many reasons.
The demand for new therapeutics is driving efforts to discover novel antibodies and harness their power in both biologics and adoptive cell therapy areas.
Japan-US research collaboration has found that red blood cells that express a novel gene may contribute to adult newt limb regeneration.
NIH study results represent a major advance for structure-based HIV vaccine design...
Researchers have developed an index that identifies the risk for lupus based on the presence and amount of IgG and IgM antibodies and levels of C1q...
This article focuses on how the immune system functions, the challenges that it presents to drug development and why there are such concerns around safety that need to be investigated in pre-clinical studies. Moreover, it covers the role of checkpoint inhibitors as an attractive target for cancer immunotherapy.
A study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of aggressive ALS...
A group of researchers have discovered an important mechanism that governs how B cells are chosen to become plasma cells...
Molecules called aptamers could form new, safer chemotherapy delivery systems...
Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum...
This application note discusses how the Alpha SureFire® Ultra™ Multiplex technology provides a phosphoprotein multiplexing detection platform that is truly homogeneous and high throughput.
This recent webinar focused on the role of IntelliCyt’s iQue Screener PLUS platform as a high throughput suspension cell screening platform to facilitate simultaneous assessment of multiple parameters, while using minimal sample volumes.
Researchers in the United States are investigating an alternative treatment to antibiotics for Klebsiella pneumoniae infections; the cause of a significant proportion of hospital-acquired illnesses.